These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 10212327)
1. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Nold G; Strobel G; Lemmer B Blood Press Monit; 1998 Feb; 3(1):17-25. PubMed ID: 10212327 [TBL] [Abstract][Full Text] [Related]
2. [Circadian rhythm of arterial pressure and use of amlodipine in primary hypertension]. Spritzer N Arq Bras Cardiol; 1993 May; 60(5):361-7. PubMed ID: 8311755 [TBL] [Abstract][Full Text] [Related]
3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737 [TBL] [Abstract][Full Text] [Related]
4. Are there differences in the effects of long-acting calcium antagonists on ambulatory blood pressure? Extended-release nisoldipine versus amlodipine as a model. Punzi HA; Noveck R; Weiss RJ; Graf R; Ruff DA; Hutchinson HG; White WB Blood Press Monit; 1998 Aug; 3(4):267-272. PubMed ID: 10212365 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine. Lacourcière Y; Lenis J; Orchard R; Lewanczuk R; Houde M; Pesant Y; Wright J; Wilson T; Martin K Blood Press Monit; 1998 Oct; 3(5):295-302. PubMed ID: 10212369 [TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
7. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol. Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F; Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Smolensky MH; Hermida RC; Portaluppi F Chronobiol Int; 2007; 24(1):171-81. PubMed ID: 17364587 [TBL] [Abstract][Full Text] [Related]
9. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
12. Effects of long-acting ACE inhibitor (temocapril) and long-acting Ca channel blocker (amlodipine) on 24-h ambulatory BP in elderly hypertensive patients. Eguchi K; Kario K; Shimada K J Hum Hypertens; 2001 Sep; 15(9):643-8. PubMed ID: 11550111 [TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
14. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946 [TBL] [Abstract][Full Text] [Related]
15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension]. Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888 [TBL] [Abstract][Full Text] [Related]
17. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fernández JR Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215 [TBL] [Abstract][Full Text] [Related]
18. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial. Pathak L; Hiremath ; Kerkar PG; Manade VG J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308 [TBL] [Abstract][Full Text] [Related]
19. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy. Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559 [TBL] [Abstract][Full Text] [Related]
20. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial). Ryuzaki M; Nakamoto H; Nishida E; Sone M; Nakajima S; Yoshimoto M; Suzuki Y; Itagaki K J Hypertens; 2007 Nov; 25(11):2352-8. PubMed ID: 17921832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]